Prague Registry of Electric Cardioversion for Supraventricular Arrhythmias
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 5,000
- 试验地点
- 1
- 主要终点
- Acute major complications
研究概览
简要总结
This single-center observational registry follows contemporary efficacy and short-term complications of elective electric cardioversion.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Consecutive out-patients undergoing electric cardioversion for atrial fibrillation, atrial tachycardia, or typical atrial flutter
排除标准
- •Unstable patients with acute conditions requiring unplanned hospitalization
结局指标
主要结局
Acute major complications
时间窗: Within 24 hours from the procedure
Major thromboembolic events or events related to cardioversion requiring unplanned hospitalisation (bleeding, severe bradycardia, anesthesia-related complications, heart failure etc)
Subacute major complications
时间窗: 24 hours to 30 days after the procedure
Major thromboembolic events or events related to cardioversion requiring unplanned hospitalisation (bleeding, severe bradycardia, anesthesia-related complications, acute heart failure etc), evaluated by structured phone call.
次要结局
- Acute minor complications(Within 24 hours from the procedure)
- Acute efficacy(Within 2 hours from the procedure)
研究者
Marek Sramko
Head of the Department of Acute Cardiology
Institute for Clinical and Experimental Medicine